Mrkt BUZZ, Nosa Plugs: Positive results and proof of concept
11 juli, 15:42
11 juli, 15:42
Carlsquare Equity Research comments on the news that NOSA achieved positive results in an in vivo study using the drug delivery plugs. The study showed that a significant level of the drug used in the study was absorbed into blood plasma, demonstrating that the delivery technology works and that therapeutically relevant levels can be achieved.
About Carlsquare
Carlsquare is a global research firm and financial advisor, focusing on M&A, Equity
Research and Growth Equity. Carlsquare has 150 employees with deep sector knowledge in all 11
GICS sectors. The senior equity research team has extensive experience about the stock
environment and several business sectors. The team produces company research reports,
independent valuations and trading notes. The group have offices in Canada, Denmark, France, Germany, Poland, Sweden, United Kingdom and United States. Read more
Contacts
MARKUS AUGUSTSSON
Head of Equity Research
markus.augustsson@carlsquare.com
+46 (0)76 235 03 20
NIKLAS ELMHAMMER
Senior Equity Analyst
niklas.elmhammer@carlsquare.com
+46 (0)70 898 39 59
Attachments
Mrkt BUZZ, Nosa Plugs: Positive results and proof of concept
11 juli, 15:42
Carlsquare Equity Research comments on the news that NOSA achieved positive results in an in vivo study using the drug delivery plugs. The study showed that a significant level of the drug used in the study was absorbed into blood plasma, demonstrating that the delivery technology works and that therapeutically relevant levels can be achieved.
About Carlsquare
Carlsquare is a global research firm and financial advisor, focusing on M&A, Equity
Research and Growth Equity. Carlsquare has 150 employees with deep sector knowledge in all 11
GICS sectors. The senior equity research team has extensive experience about the stock
environment and several business sectors. The team produces company research reports,
independent valuations and trading notes. The group have offices in Canada, Denmark, France, Germany, Poland, Sweden, United Kingdom and United States. Read more
Contacts
MARKUS AUGUSTSSON
Head of Equity Research
markus.augustsson@carlsquare.com
+46 (0)76 235 03 20
NIKLAS ELMHAMMER
Senior Equity Analyst
niklas.elmhammer@carlsquare.com
+46 (0)70 898 39 59
Attachments
Mrkt BUZZ, Nosa Plugs: Positive results and proof of concept
Rapportperioden
Plejd
Inflationen
Rapportperioden
Plejd
Inflationen
1 DAG %
Senast
sbab
Idag, 10:15
SBAB:s krympande intäkter
OMX Stockholm 30
1 DAG %
Senast
2 526,03